NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 126 filers reported holding NUVATION BIO INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $237,765 | +18.6% | 174,827 | +56.1% | 0.00% | – |
Q2 2023 | $200,473 | +21.4% | 111,983 | +12.6% | 0.00% | – |
Q1 2023 | $165,076 | +7.3% | 99,443 | +21.2% | 0.00% | – |
Q4 2022 | $153,910 | +133.2% | 82,030 | +192.0% | 0.00% | – |
Q3 2022 | $66,000 | -32.7% | 28,089 | +165.3% | 0.00% | – |
Q2 2021 | $98,000 | – | 10,587 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 15,072,340 | $28,938,893 | 9.75% |
Aisling Capital Management LP | 2,541,009 | $4,878,737 | 3.22% |
EDBI Pte Ltd | 1,270,504 | $2,439,368 | 3.11% |
EcoR1 Capital, LLC | 13,896,543 | $26,681,363 | 0.81% |
Deep Track Capital, LP | 8,221,188 | $15,784,681 | 0.66% |
AlphaCentric Advisors LLC | 325,000 | $624,000 | 0.62% |
683 Capital Management, LLC | 2,500,000 | $4,799,999 | 0.41% |
BRAIDWELL LP | 4,122,900 | $7,915,968 | 0.26% |
Abrams Capital Management | 3,811,513 | $7,318,105 | 0.26% |
Redmile Group, LLC | 3,031,009 | $5,819,537 | 0.24% |